Pioneering 3D printing medical device manufacturer Meticuly selected from over 660 applicants worldwide to emerge as a winner of the coveted WIPO Global Awards 2024
Geneva, 12th July 2024 – Meticuly, a company pioneering 3D printing medical implants, has been chosen as the first Thai company globally to receive the esteemed WIPO Global Award from the World Intellectual Property Organization (WIPO). This prestigious prize acknowledges Meticuly's dedication to innovation and serves to recognise the company’s robust intellectual property (IP) foundations.
The WIPO Global Awards spotlight the achievements of small and medium-sized enterprises (SMEs) that have achieved commercial success and innovation by strategically utilising IP rights. Meticuly's inventive approach to revolutionise medical 3D printing and IP protection has enabled the creation of technologies that address pressing healthcare challenges, earning the company this distinguished honour.
“We started off with one dream that quickly expanded into 4 intellectual properties serving as the original foundation of our company. These intellectual properties helped us to fundraise and gain investments. This is a testament to how WIPO’s efforts support companies like ours to thrive and make a meaningful impact in healthcare.” said Boonrat Lohwongwatana, Co-founder & CEO of Meticuly.
The WIPO Global Awards ceremony took place on 12th July 2024 in Geneva, Switzerland, during the 65th WIPO General Assembly of Member States, where Meticuly was honoured alongside other winners from around the world.
How Meticuly’s IP assets drive profitable commercial ventures
Meticuly’s robust portfolio of intellectual property assets has been a cornerstone in driving profitable commercial ventures. With 36 patents and 18 trademarks across 10 countries, our IP strategy secures exclusive rights that protect our innovations in AI-predictive design and metal additive manufacturing for personalised medical implants. These IP assets have enabled us to capture significant market share and generate substantial revenue streams. By maintaining a strong focus on IP management, we ensure that our technological advancements remain proprietary, giving us a distinct competitive edge in the industry and driving our commercial success.
Leveraging IP for business growth
Leveraging our IP for business growth is a key component of Meticuly’s strategy. Our extensive portfolio not only protects our innovations but also acts as a catalyst for new business opportunities. With two products in the cranio-maxillofacial mesh family having received U.S. FDA 510(k) clearances, and a quality management system certified by ISO 13485 and MDSAP, we enhance our credibility and marketability. By licensing our IP, forming strategic alliances, and engaging in collaborative research, we expand our market presence and enhance our product offerings. This proactive approach to IP management facilitates continuous growth, positioning us as a leader in the market and enabling us to better serve the healthcare sector.
Delivering commercial solutions for sustainable impact
Delivering commercial solutions that impact the Sustainable Development Goals (SDGs) is integral to Meticuly’s mission. Our innovations are designed with a focus on sustainability, addressing critical global challenges such as healthcare accessibility and quality. Through our groundbreaking medical devices, we have enabled over 1,800 patients to regain mobility and quality of life, with projections to impact more than 10,000 patients annually. By aligning our commercial ventures with the SDGs, we ensure that our business growth contributes to a more sustainable and equitable world. Making healthcare easier and treatments more accessible - that's what 'Personalised medical solutions for better lives' means to us.
Read more about sustainability at Meticuly in our 2023 ESG report.
About the WIPO Global Awards
The WIPO Global Awards recognize small and medium-sized enterprises (SMEs) that have successfully leveraged IP rights to drive innovation and commercial success. The awards are presented by the World Intellectual Property Organization (WIPO), a specialised agency of the United Nations.
Comments